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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of evidence. 
Dignity not destitution: An ‘Economic Rescue Plan For All’ to tackle the coronavirus crisis 
and rebuild a more equal world 
Oxfam | 9 April 2020 | Policy Paper 
https://www.oxfam.org/en/research/dignity-not-destitution 
Analysis reported in this paper shows that over half a billion people could be pushed into poverty 
unless action is taken now. An Economic Rescue Plan For All is included requiring mobilisation of 
at least $2.5 trillion dollars to tackle the pandemic and prevent global economic collapse. This 
includes actions to help people and businesses needed now – cash grants and responsible 
business bail out – supported by actions including suspension and cancellation of debts, a one-off 
global economic stimulus by the IMF, increase in aid and adoption of emergency solidarity taxes.  
Strengthening the Basics: approaches to COVID-19 care in low-resource settings 
Ismail et al. | Center for Global Development | 8 April 2020 | Blog 
https://www.cgdev.org/blog/strengthening-basics-approaches-covid-19-care-low-resource-
settings 
This blog focuses on hospital treatment for COVID-19 patients in low-resource settings given what 
we know about the spectrum of COVID-19 illness, healthcare capacity and a need for prioritisation 
of resources. Models of care from high-income settings are likely to be inappropriate where 
resources are scarce. The priority is to identify interventions that can be implemented at pace and 
maximise lives saved. This includes (1) prioritise simple hospital interventions to save the most 
lives; (2) align global-development-partners-supported commodity procurement with country 
realities to enable delivery of the highest value interventions; and (3) carry out pragmatic research 
to understand what works in low-resource settings in support of a learning healthcare system. 
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First-wave COVID-19 transmissibility and severity in China outside Hubei after control 
measures, and second-wave scenario planning: a modelling impact assessment 
Leung, K. et al. | The Lancet | 8 April 2020 | Article 
https://doi.org/10.1016/S0140-6736(20)30746-7 
In four cities and ten provinces in China outside Hubei, the instantaneous reproduction number 
(Rt) of COVID-19 substantially decreased after massive public health control interventions were 
implemented across China on 23 January 2020 to contain the spread of COVID-19 and have since 
remained below 1. The confirmed case-fatality risk (cCFR) outside Hubei was 0.98%, but varied 
substantially among different provinces, probably due to heterogeneity in regional economic 
development and healthcare capacity. Real-time monitoring of transmissibility (Rt) and severity 
(cCFR) are needed as control measures are relaxed gradually so that the resulting Rt does not 
sustainably exceed 1, especially given the substantial risk of viral reintroduction including from 
overseas importation, to inform strategies to minimise a second wave and achieve optimal balance 
between health and economic protection.  
Beware of the second wave of COVID-19 
Xu, S. & Li, Y. | The Lancet | 8 April 2020 | Comment 
https://doi.org/10.1016/S0140-6736(20)30845-X 
This Comment on Kathy Leung and colleagues report (above) highlights that SARS-CoV-2 
transmission outside Hubei until late January was mainly driven by imported cases from Hubei and 
after 31 January spread in these provinces was believed to be driven by local transmission. This 
suggests that the package of non-pharmaceutical interventions in China has the ability to contain 
transmission from imported cases and local transmission. This study also modelled the potential 
adverse consequences of relaxing interventions finding that if this is done prematurely, these 
decisions may lead to transmissibility exceeding 1 again and a second wave of infections. The 
effect of each intervention was not addressed in the study, but this information is needed to guide 
countries as they relax interventions. Country-specific models of the effects of travel restrictions, 
social distancing and alternative strategies after relaxation of these interventions, such as use of 
face masks, temperature checks and contact tracing, are now needed. Leung and colleagues 
estimated the confirmed CFR outside Hubei was 0.98% (95% CI 0.82-1.16), consistent with the 
report from the Chinese Center for Disease Control and Prevention, but this is in contrast to the 
CFR in Wuhan - up to 5.08% by 28 March 2020, possibly attributable to the difference in healthcare 
capacity where it was not overwhelmed in the study locations. 
Tuberculosis and HIV responses threatened by COVID-19 
Adepoju, P. | The Lancet HIV | 8 April 2020 | Feature 
https://doi.org/10.1016/S2352-3018(20)30109-0 
In Africa the TB epidemic is driven by HIV which may also make these people susceptible to 
coronavirus. WHO and UNAIDS are compiling data and evidence to guide recommendations for 
the management of COVID-19 in the context of HIV-TB co-infection. COVID-19 is already though 
affecting control measures for TB and HIV and there is a real potential disruption to supply and 
transportation of TB drugs by flight cancellations and imposed travel restrictions. There are also 
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concerns of healthcare workers and laboratory staff in Nigeria in handling samples for TB testing 
due to lack of protective materials. In a TB clinic in Ibadan, Nigeria, TB patients, many of whom 
reply on public transportation to commute to the clinic, have not collected drug supplies for fear of 
discrimination. Restocking of the drug store was not possible given the time to give patients 
sufficient doses of their drugs to last for months. UNAIDS is working with people living with HIV 
and key population networks to understand the needs for information and support for COVID-19 
prevention and continuity of HIV service. COVID-19 testing, surveillance and prevention in high 
risk settings including slums and informal settlements needs to be intensified to protect those most 
vulnerable. 
Reconciling COVID-19 death data in the UK 
Oke, J & Heneghan C | Centre for Evidence-based Medicine University of Oxford | 8 April 2020 
https://www.cebm.net/covid-19/reconciling-covid-19-death-data-in-the-uk/ 
In England and the UK, there are three main sources of death data – PHE, NHS England and 
Office for National Statistics and cumulative numbers of deaths by different data sources in 
England differ by date reported. This piece recommends that NHS England and PHE prioritise the 
date of death to provide a better understanding of the peak deaths in the pandemic.  
Tracking COVID-19 cases 
Global 
WHO COVID-19 daily situation reports 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports 
Johns Hopkins University COVID-19 dashboard in real time 
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467
b48e9ecf6 
WEF: Visualisation tracking confirmed cases of COVID-19 as it spreads. Updated daily. 
https://wef-prod.earthtime.org/m/stories/2019_nCOV_infection 
Vaccine Centre, LSHTM  
https://vac-lshtm.shinyapps.io/ncov_tracker/ 
This site complements the WHO and Johns Hopkins University COVID-19 dashboards by 
including the timeline functions, the ability to overlay past outbreaks, and an emphasis on 
normalised counts (per 100,000 individuals). 
Live data tracker: sex-disaggregated COVID-19 data from the 25 most-affected countries 
http://globalhealth5050.org/covid19 
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Africa 
Coronavirus in Africa Tracker: How many covid-19 cases & where? 
https://africanarguments.org/2020/03/23/coronavirus-in-africa-tracker-how-many-cases-and-
where-latest/ 
UK 
PHE dashboard of UK COVID-19 Cases  
https://www.arcgis.com/apps/opsdashboard/index.html#/f94c3c90da5b4e9f9a0b19484dd4bb14 
Tools 
WhatsApp coronavirus information hub 
https://www.whatsapp.com/coronavirus 
CMMID Repository: Effectiveness of airport screening at detecting travellers infected with 
COVID-19 
https://cmmid-lshtm.shinyapps.io/traveller_screening/ 
App to model effectiveness of airport screening. 
Disability Inclusive Community Action – COVID-19 Matrix 
CBM | 30 March 2020 | Tool 
https://www.cbm.org/news/news/news-2020/cbm-develops-disability-inclusive-community-action-
covid-19-matrix/ 
Online learning and events 
Online event: Policy modelling for COVID-19: Better data for better decision-making in low 
and middle-income countries 
Tuesday 14 April 2020 0900-1030 ET | Center for Global Development  
https://www.cgdev.org/event/policy-modelling-covid-19-better-data-better-decision-making-low-
and-middle-income-countries 
Moderator: Kalipso Chalkidou (CDG). Features Dan Ollendorf (CGD), Yot Teerawattananon 
(Thai Ministry of Public Health) and Anna Vassall (LSHTM) 
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Online Event: Approaching COVID-19 Risk and Response through a Gender Lens 
Thursday 9 April 2020 1300-1430 ET | Center for Global Development 
https://www.cgdev.org/event/approaching-covid-19-risk-and-response-through-gender-lens 
Moderator Megan O’Donnell (CGD). Features Gary Barker (Promundo), Carleigh Krubiner 
(CGD), Amber Peterman (University of North Carolina Chapel Hill), Crystal Simeoni (FEMNET), 
Clare Wenham (LSE), Olabukunola Williams (Education as a Vaccine) 
COVID-19 Diagnostics and Testing 
FIND, LSHTM & ASLM | FutureLearn course | Starts 20 April 2020 | 3 weeks | 3 hours weekly 
study | Free 
https://www.futurelearn.com/courses/covid-19-diagnostics-and-testing 
This course is designed for professionals involved in the testing and diagnosis of COVID-19, with 
a focus on low- and middle-income settings. You will learn the latest recommendations on COVID-
19 testing, get upt0date information on the performance of tests and how best to deploy them. 
COVID-19 Critical Care: Understanding and Application 
University of Edinburgh & Royal College of Physicians of Edinburgh  | FutureLearn course | 
Starts 6 April 2020 | 5 weeks | 1 hour weekly study | Free 
https://www.futurelearn.com/courses/covid-19-critical-care-education-resource 
Designed for frontline clinical staff to learn the principles and practice of critical care to treat and 
care for critically ill patients during the COVID-19 pandemic. You will learn (1) how to apply the 
current and evolving principles of PPE in the care of COVID-19; (2) apply evidence-based 
principles of advanced organ support and monitoring to the COVID-19 critically ill patients; (3) 
apply evidence-based daily practices to care of the critically ill patient; and (4) develop a range of 
specialised self-caring practices. 
Note that this resource has been created in response to the COVID-19 emergency and does not 
correspond to the classic structure of a FutureLearn course. You do not have to follow the week 
by week approach and can select the materials most relevant to your work. 
Emerging respiratory viruses, including COVID-19: methods for detection, prevention, 
response and control 
WHO | Free | 3 hours duration  
https://openwho.org/courses/introduction-to-ncov 
A general introduction to enable you to describe the fundamental principles of emerging 
respiratory viruses, including novel coronaviruses, and how to effectively respond to an outbreak. 
Intended for public health professionals, incident managers and personnel working for the UN, 
international organisations and NGOs. 
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Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
https://openwho.org/channels/covid-19 
Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 23 March 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
A reminder that this course is currently running. On this course you will learn what is known 
about the outbreak of COVID-19 (week 1); what the practical implications for responding to 
COVID-19 are (week 2); and what we need to find out about COVID-19 (week 3). 
Resource Hubs 
Resources on coronavirus and disability 
https://asksource.info/covid-resources/search 
ODI Coronavirus: latest research and analysis on the implications of the coronavirus 
pandemic worldwide 
https://www.odi.org/our-work/coronavirus 
International Disability and Development Consortium and CORE Group: Repository of 
resources on disability inclusion and COVID-19 
https://docs.google.com/document/d/1IVP1u6yHfLuN9qNyLEct5-vtC0aqLKtKr-o-faAjves/edit 
US NIH online platform of all registered, ongoing clinical trials globally 
https://clinicaltrials.gov/ct2/results?cond=COVID-19 
COVID-19 Narratives by Dr David Nabarro 
https://www.4sd.info/covid-19-narratives/ 
These narratives are being written by David Nabarro, Co-Director of the Imperial College Institute 
of Global Health Innovation at Imperial College London, Strategic Director for 4SD and one of six 
Special Envoys to the WHO DG Special Envoy on COVID-19, and peers to share with those who 
want more information about the situation and to help raise the awareness and readiness of all 
actors. Please visit WHO website for official guidance.  
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Reliefweb COVID-19 
https://reliefweb.int/topics/covid-19 
Coronavirus global health emergency 
https://www.un.org/coronavirus 
Norwegian Institute of Public Health: Live map of COVID-19 evidence 
https://www.fhi.no/en/qk/systematic-reviews-hta/map/ 
Overview of scientific publications on COVID-19 categorised into subgroups to provide quick 
access to specific topic-relevant publications to help decision makers and research navigate the 
research and help identify research gaps.  
Vaccine Centre at LSHTM: COVID-19 vaccine development pipeline tracker 
https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/ 
COVID-19 Research Project Tracker by UKCDR & GloPID-R 
https://www.ukcdr.org.uk/funding-landscape/covid-19-research-project-tracker/ 
A live database of funded research projects across the world related to COVID-19 mapped against 
the priorities identified in the WHO Coordination Global Research Roadmap: 2019 Novel 
Coronavirus. 
WHO Q&A on COVID-19 
https://www.who.int/news-room/q-a-detail/q-a-coronaviruses 
Note that this resource includes Q&A on COVID-19; COVID-19, pregnancy, childbirth and 
breastfeeding; COVID-19, HIV and antiretrovirals; similarities and differences COVID-19 and 
influenza; mass gatherings and COVID-19; IPC for healthcare workers; COVID-19 and food and 
agriculture; smoking and COVID-19; malaria and COVID-19. 
COVID-19: Resources and research on epidemics and pandemics 
https://steps-centre.org/covid-19-coronavirus-resources-research-epidemics-pandemics/ 
Stop TB Partnership TB and COVID-19 
http://www.stoptb.org/covid19.asp 
EPI-WIN: WHO information network for epidemics: COVID-19 public health emergency 
https://www.who.int/teams/risk-communication 
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COVID-19: Research ethics 
https://ethicsresource.ringsgenderresearch.org/covid-19-resources/ 
LSTM: COVID-19 
https://www.lstmed.ac.uk/covid-19 
LSHTM: COVID-19 
https://www.lshtm.ac.uk/research/research-action/covid-19 
International Disability Alliance: COVID 19 and the disability movement 
http://www.internationaldisabilityalliance.org/content/covid-19-and-disability-movement 
Africa Centres for Disease Control and Prevention (Africa CDC) 
https://africacdc.org/covid-19/ 
UNICEF: Latest news and updates on coronavirus disease 2019 (COVID-19) 
https://www.unicef.org/coronavirus/covid-19 
Coronavirus: the science explained 
https://coronavirusexplained.ukri.org/en/ 
Social Science in Humanitarian Action: Updates on the novel COVID-19 outbreak 
https://www.socialscienceinaction.org/update-novel-covid-19-outbreak/ 
Special Collection: Coronavirus (COVID-19): evidence relevant to critical care 
https://www.cochrane.org/news/special-collection-coronavirus-covid-19-evidence-relevant-
critical-care 
NICE UK: Rapid guidelines and evidence reviews  
https://www.nice.org.uk/covid-19 
Imperial College London MRC Centre for Global Infectious Disease Analysis COVID-19 
reports 
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ 
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Global research on COVID-19 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-
coronavirus-2019-ncov 
WHO R&D Blueprint 
https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/ 
WHO: Coronavirus disease (COVID-19) outbreak resources 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 
Latest information and advice from the UK Government 
https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public 
CDC COVID-19 Resources 
https://www.cdc.gov/coronavirus/2019-ncov/index.htmlThe Global Health Network Coronavirus 
outbreak knowledge hub 
The Lancet COVID-19 Resource Centre 
https://www.thelancet.com/coronavirus 
Elsevier’s Novel Coronavirus Information Center 
https://www.elsevier.com/connect/coronavirus-information-center 
Cell Press Coronavirus Resource Hub 
https://www.cell.com/2019-nCOV 
Cochrane Special Collections - COVID-19: infection control and prevention measures 
https://www.cochranelibrary.com/collections/doi/SC000040/full 
The BMJ Coronavirus (covid-19): Latest news and resources 
https://www.bmj.com/coronavirus?int_source=wisepops&int_medium=wisepops&int_campaign=
DAA_CoronaVirus_Jan24 
Johns Hopkins Coronavirus Resource Centre 
https://coronavirus.jhu.edu 
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Global Partnership for Sustainable Development – COVID-19 resources 
http://www.data4sdgs.org/resources/covid-19-resources 
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